RU94042899A - Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен - Google Patents
Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофенInfo
- Publication number
- RU94042899A RU94042899A RU94042899/14A RU94042899A RU94042899A RU 94042899 A RU94042899 A RU 94042899A RU 94042899/14 A RU94042899/14 A RU 94042899/14A RU 94042899 A RU94042899 A RU 94042899A RU 94042899 A RU94042899 A RU 94042899A
- Authority
- RU
- Russia
- Prior art keywords
- ketoprofen
- analgetic
- treatment
- optically pure
- hyperthermia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Accessories For Mixers (AREA)
Abstract
Предложены способы и композиции, использующие оптически чистый R (-) кетопрофен для лечения зубной боли, головной боли, боли, связанной с растяжениями, боли в суставах и послехирургической боли, например, стоматологической и офтальмической, но не ограничиваясь ею, при существенном уменьшении неблагоприятных побочных эффектов, включая желудочно-кишечные, почечные и печеночные токсичности и лейкоцитопению, но не ограничиваясь ими, связанных с применением рацемического кетопрофена. Оптически чистый R (-) кетопрофен также пригоден для лечения гипертермии, при существенном уменьшении неблагоприятных побочных эффектов, связанных с применением рацемического кетопрофена.
Claims (1)
- Предложены способы и композиции, использующие оптически чистый R (-) кетопрофен для лечения зубной боли, головной боли, боли, связанной с растяжениями, боли в суставах и послехирургической боли, например, стоматологической и офтальмической, но не ограничиваясь ею, при существенном уменьшении неблагоприятных побочных эффектов, включая желудочно-кишечные, почечные и печеночные токсичности и лейкоцитопению, но не ограничиваясь ими, связанных с применением рацемического кетопрофена. Оптически чистый R (-) кетопрофен также пригоден для лечения гипертермии, при существенном уменьшении неблагоприятных побочных эффектов, связанных с применением рацемического кетопрофена.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84845892A | 1992-03-09 | 1992-03-09 | |
US848,458 | 1992-03-09 | ||
US08/024,728 US5331000A (en) | 1992-03-09 | 1993-03-01 | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
US024,728 | 1993-03-01 | ||
PCT/US1993/002126 WO1993017677A1 (en) | 1992-03-09 | 1993-03-08 | Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen |
US848458 | 2001-05-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94042899A true RU94042899A (ru) | 1996-10-20 |
RU2125873C1 RU2125873C1 (ru) | 1999-02-10 |
Family
ID=26698799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94042899A RU2125873C1 (ru) | 1992-03-09 | 1993-03-08 | Болеутоляющая композиция и способ достижения болеутоляющего эффекта у человека |
Country Status (10)
Country | Link |
---|---|
US (1) | US5331000A (ru) |
EP (1) | EP0630239A4 (ru) |
JP (1) | JPH07507057A (ru) |
AU (2) | AU673998B2 (ru) |
BR (1) | BR9306067A (ru) |
CA (2) | CA2131802A1 (ru) |
HU (1) | HUT68820A (ru) |
NZ (1) | NZ251138A (ru) |
RU (1) | RU2125873C1 (ru) |
WO (1) | WO1993017677A1 (ru) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671800B1 (fr) * | 1991-01-17 | 1993-03-12 | Rhone Poulenc Rorer Sa | Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent. |
US5786357A (en) | 1991-12-02 | 1998-07-28 | Sepracor Inc. | Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone |
US5981591A (en) * | 1992-12-04 | 1999-11-09 | Mayor Pharmaceutical Laboratories, Inc. | Sprayable analgesic composition and method of use |
WO1994020449A1 (en) * | 1993-03-09 | 1994-09-15 | Dompe'farmaceutici Spa | Salts of 2-(3-benzoylphenyl)propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof |
DE4319438C1 (de) * | 1993-06-11 | 1994-06-01 | Gerd Dr Dr Geislinger | Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren |
EP0785779A1 (en) * | 1994-03-18 | 1997-07-30 | Bayer Corporation | Low dosage ketoprofen |
JPH08151344A (ja) * | 1994-09-26 | 1996-06-11 | Nagase & Co Ltd | 2−(3−ベンゾイルフェニル)プロピオン酸の光学分割方法 |
US6160018A (en) * | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
US5955504A (en) * | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
US5981592A (en) * | 1995-03-13 | 1999-11-09 | Loma Linda University Medical Center | Method and composition for treating cystic fibrosis |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
US5922736A (en) * | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
US5733756A (en) * | 1996-01-05 | 1998-03-31 | Celgene Corporation | Lactams and processes for stereoselective enrichment of lactams, amides, and esters |
US6486177B2 (en) * | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
US5908850A (en) * | 1995-12-04 | 1999-06-01 | Celgene Corporation | Method of treating attention deficit disorders with d-threo methylphenidate |
US6355656B1 (en) | 1995-12-04 | 2002-03-12 | Celgene Corporation | Phenidate drug formulations having diminished abuse potential |
FR2742054B1 (fr) * | 1995-12-06 | 1998-01-09 | Synthelabo | Compositions pharmaceutiques contenant un agent anti-inflammatoire et des ceramides vegetales |
IT1277741B1 (it) * | 1995-12-28 | 1997-11-12 | Dompe Spa | Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici |
US6767925B1 (en) | 1996-10-31 | 2004-07-27 | Joseph A. Deihl | Sprayable analgesic composition and method of use |
DK0966277T3 (da) * | 1997-03-10 | 2006-03-27 | Univ Loma Linda Med | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom |
US6962997B1 (en) * | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
IT1298214B1 (it) * | 1998-01-28 | 1999-12-20 | Dompe Spa | Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche. |
US6197347B1 (en) | 1998-06-29 | 2001-03-06 | Andrx Pharmaceuticals, Inc. | Oral dosage for the controlled release of analgesic |
GB2339534A (en) * | 1998-07-16 | 2000-02-02 | Edko Trading Representation | Epidural or intrathecal administration of NSAID's |
PT1143958E (pt) | 1998-09-03 | 2007-04-30 | Univ Loma Linda Med | Composição farmacêutica e utilização de rnsaid para o tratamento da inflamação. |
US7067144B2 (en) | 1998-10-20 | 2006-06-27 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
US6362227B1 (en) * | 1999-03-02 | 2002-03-26 | Sepracor, Inc. | Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen |
EP1284729A4 (en) * | 2000-04-13 | 2007-12-19 | Mayo Foundation | REDUCTION AGENTS OF A (BETA) 42 |
EA200802070A1 (ru) * | 2000-06-13 | 2009-06-30 | Вайет | Болеутоляющее и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2 |
DE10047319A1 (de) | 2000-09-25 | 2002-04-18 | Paz Arzneimittelentwicklung | Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen, welche durch die Hemmung der Aktivierung des nukleären Transkriptionsfaktors AP-1 therapeutisch beeinflußt werden können |
US6534676B2 (en) * | 2001-01-31 | 2003-03-18 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
US20030027867A1 (en) * | 2001-06-29 | 2003-02-06 | Myriad Genetics, Incorporated | Use of R-NSAID compounds for anti-HIV treatment |
FR2833173B1 (fr) * | 2001-12-10 | 2004-08-27 | Roquette Freres | Preparation antipyretique renfermant du xylitol |
EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS |
EP1651195A4 (en) * | 2003-07-11 | 2007-10-03 | Myriad Genetics Inc | PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE |
US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
US20050239830A1 (en) * | 2004-04-26 | 2005-10-27 | Vikram Khetani | Methods of diminishing co-abuse potential |
EP1745180A1 (en) * | 2004-04-29 | 2007-01-24 | Keystone Retaining Wall Systems, Inc. | Veneers for walls, retaining walls and the like |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
CA2618985A1 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
EP1830648A4 (en) * | 2004-12-09 | 2008-03-12 | Celgene Corp | TREATMENT WITH D-THREO-METHYLPHENIDATE |
JP2009500420A (ja) * | 2005-07-06 | 2009-01-08 | セプラコア インコーポレーテッド | エスゾピクロン及びo−デスメチルベンラファキシンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 |
BRPI0613611A2 (pt) * | 2005-07-22 | 2011-01-18 | Myriad Genetics Inc | formulações de alta concentração de fármaco e formas de dosagens |
EP2046119A2 (en) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
WO2008012605A1 (en) * | 2006-07-27 | 2008-01-31 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate |
US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
US20090238763A1 (en) * | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
US9371284B2 (en) | 2007-06-04 | 2016-06-21 | Techfields Pharma Co., Ltd. | Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses |
US20080305171A1 (en) * | 2007-06-07 | 2008-12-11 | Kristin Anne Arnold | Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
KR20230085223A (ko) * | 2008-12-04 | 2023-06-13 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
EP3907214A1 (en) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1546478A (fr) * | 1967-01-27 | 1968-11-22 | Rhone Poulenc Sa | Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation |
US4962124A (en) * | 1987-11-17 | 1990-10-09 | Analgesic Associates | Onset-hastened/enhanced antipyretic response |
US4868214A (en) * | 1987-11-17 | 1989-09-19 | Analgesic Associates | Onset-hastened/enhanced analgesia |
US4927854A (en) * | 1987-12-24 | 1990-05-22 | Analgesic Associates | Sustained/enhanced analgesia |
US5057427A (en) * | 1988-04-07 | 1991-10-15 | Sepracor, Inc. | Method for resolution of stereoisomers |
DE3814887C1 (ru) * | 1988-05-02 | 1989-09-21 | Medice Chem.-Pharm. Fabrik Puetter Gmbh & Co Kg, 5860 Iserlohn, De | |
SU1687678A1 (ru) * | 1988-08-02 | 1991-10-30 | Предприятие П/Я А-7650 | Швейна машина |
FR2651494B1 (fr) * | 1989-09-05 | 1993-01-08 | Rhone Poulenc Sante | Procede de preparation d'acides aryl-2 propioniques optiquement actifs. |
US5114714A (en) * | 1990-11-29 | 1992-05-19 | Sepracor, Inc. | Methods of use and compositions of (r)-isoflurane and (r)-desflurane |
US5114715A (en) * | 1990-11-29 | 1992-05-19 | Sepracor Inc. | Methods of use and compositions of (s)-isoflurane and (s)-desflurane |
FR2687915B1 (fr) | 1992-02-28 | 1995-05-05 | Rhone Poulenc Rorer Sa | Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r). |
DE4319438C1 (de) * | 1993-06-11 | 1994-06-01 | Gerd Dr Dr Geislinger | Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren |
-
1993
- 1993-03-01 US US08/024,728 patent/US5331000A/en not_active Expired - Lifetime
- 1993-03-08 RU RU94042899A patent/RU2125873C1/ru active
- 1993-03-08 JP JP5515969A patent/JPH07507057A/ja active Pending
- 1993-03-08 AU AU37989/93A patent/AU673998B2/en not_active Ceased
- 1993-03-08 HU HU9402594A patent/HUT68820A/hu unknown
- 1993-03-08 BR BR9306067A patent/BR9306067A/pt not_active Application Discontinuation
- 1993-03-08 NZ NZ251138A patent/NZ251138A/en unknown
- 1993-03-08 CA CA002131802A patent/CA2131802A1/en not_active Abandoned
- 1993-03-08 EP EP93907353A patent/EP0630239A4/en not_active Withdrawn
- 1993-03-08 WO PCT/US1993/002126 patent/WO1993017677A1/en not_active Application Discontinuation
- 1993-04-22 CA CA002094683A patent/CA2094683A1/en not_active Abandoned
-
1996
- 1996-10-23 AU AU70334/96A patent/AU690860B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU673998B2 (en) | 1996-12-05 |
AU690860B2 (en) | 1998-04-30 |
EP0630239A1 (en) | 1994-12-28 |
HUT68820A (en) | 1995-07-28 |
CA2131802A1 (en) | 1993-09-16 |
RU2125873C1 (ru) | 1999-02-10 |
CA2094683A1 (en) | 1994-10-23 |
JPH07507057A (ja) | 1995-08-03 |
BR9306067A (pt) | 1998-01-13 |
AU7033496A (en) | 1996-12-19 |
AU3798993A (en) | 1993-10-05 |
HU9402594D0 (en) | 1994-11-28 |
US5331000A (en) | 1994-07-19 |
WO1993017677A1 (en) | 1993-09-16 |
NZ251138A (en) | 1997-06-24 |
EP0630239A4 (en) | 1995-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94042899A (ru) | Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен | |
ATE150969T1 (de) | Antipyretische und analgetische zusammensetzungen, die optisch reines r-ketorolac enthalten | |
NO934102L (no) | Terapeutisk preparat | |
RU93058389A (ru) | Фармацевтическая композиция, содержащая s(-)-2-(4-изобутилфенил)пропионат натрия, способ ее получения, применение композиции, способы получения натриевой соли энантиомера 2-(4-изобутилфенил)пропионовой кислоты, s(-)-2-(4-изобутилфенил)пропионата натрия дигидрат | |
RU92016445A (ru) | Применение амидов изоксазол-4-карбоновой кислоты и амидов гидроксиалкилиденциануксусной кислоты | |
TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
ATE193648T1 (de) | Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten | |
RU93055870A (ru) | Производные бифенила, способ их получения и фармацевтическая композиция для лечения гипертонии и сердечных заболеваний | |
ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
NO960347D0 (no) | Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF | |
GR3015937T3 (en) | Salts of the 2-(2,6-dichloroanilino)-phenylacetic acid, process for their preparation and their application as pharmaceutical preparations for topical use. | |
RU2000113873A (ru) | Способ лечения воспалительного суставного синдрома и состав для его осуществления | |
KR950700058A (ko) | 광학적으로 순수한 r(-)케토프로펜을 포함하는 해열제와 무통 조성물 및 그 방법(antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen) | |
RU99108789A (ru) | Ингибитор субэпителиального помутнения роговицы |